VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $822,154,000 | +68072.0% | 4,609 | -16.1% | 0.07% | +18.3% |
| Q2 2015 | $1,206,000 | +23.3% | 5,496 | +12.2% | 0.06% | +172.7% |
| Q1 2015 | $978,000 | +70.1% | 4,900 | +21.9% | 0.02% | -37.1% |
| Q4 2014 | $575,000 | -5.4% | 4,021 | -16.6% | 0.04% | -12.5% |
| Q2 2014 | $608,000 | -16.4% | 4,823 | -12.6% | 0.04% | -34.4% |
| Q1 2014 | $727,000 | -4.0% | 5,517 | -14.4% | 0.06% | -18.7% |
| Q4 2013 | $757,000 | -39.8% | 6,444 | -46.5% | 0.08% | -49.3% |
| Q3 2013 | $1,257,000 | +19.6% | 12,053 | -1.2% | 0.15% | +6.5% |
| Q2 2013 | $1,051,000 | – | 12,204 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |